Beijing Scitop Bio-tech Co., Ltd. (SHE:300858)

China flag China · Delayed Price · Currency is CNY
16.84
+0.16 (0.96%)
Mar 9, 2026, 3:04 PM CST
33.44%
Market Cap 4.44B
Revenue (ttm) 351.47M
Net Income (ttm) 99.40M
Shares Out 263.50M
EPS (ttm) 0.38
PE Ratio 44.30
Forward PE 26.73
Dividend 0.15 (0.90%)
Ex-Dividend Date Jul 16, 2025
Volume 4,392,919
Average Volume 3,666,431
Open 16.65
Previous Close 16.68
Day's Range 16.45 - 17.08
52-Week Range 11.03 - 24.66
Beta 0.58
RSI 37.88
Earnings Date Apr 22, 2026

About Beijing Scitop Bio-tech

Beijing Scitop Bio-tech Co., Ltd. researches, develops, produces, and sells probiotic, postbiotics, and microecologival preparations for animals and plants in China. It provides probiotic and postbiotics for gastrointestinal health, immune regulation, oral health, sleep aid and stress relief, women’s health, slimming and fat reduction, kidney and liver protection, blood sugar regulation, allergy relief, blood pressure regulation, and mother-infant transmission, as well as exercise, bone, heart, and skin health applications. The company also off... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2003
Employees 295
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300858
Full Company Profile

Financial Performance

In 2024, Beijing Scitop Bio-tech's revenue was 302.79 million, an increase of 1.19% compared to the previous year's 299.24 million. Earnings were 94.36 million, an increase of 0.94%.

Financial Statements

News

There is no news available yet.